leadf
logo-loader
RNS
viewHikma Pharmaceuticals PLC

Hikma Pharmaceutical - Director/PDMR Shareholding

RNS Number : 5272E
Hikma Pharmaceuticals Plc
28 February 2020
 

Hikma Pharmaceuticals PLC

Notification and public disclosure of transactions by persons discharging managerial responsibilities

Said Darwazah

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Said Darwazah

2

Reason for the notification

a)

Position/status

Executive Chairman

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Hikma Pharmaceuticals PLC

b)

LEI

549300BNS685UXH4JI75

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Description: Ordinary shares of 10 pence each

ID Code: GB00B0LCW083

b)

Nature of the transaction

 

Release of a pledge by Darhold Limited over 1,000,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC in favour of Bank J. Safra Sarasin.  The Executive Chairman is a director of and shareholder in Darhold Limited with an equity interest of 21.99%.

c)

Price(s) and volume(s)

Price(s): £0.00p

Volume(s): 1,000,000

d)

Aggregated information

Aggregated volume: 1,000,000

Price: £0.00p

e)

Date of the transaction

28 February 2020

f)

Place of the transaction

Amman

 Mazen Darwazah

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Mazen Darwazah

2

Reason for the notification

a)

Position/status

Executive Vice Chairman

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Hikma Pharmaceuticals PLC

b)

LEI

549300BNS685UXH4JI75

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Description: Ordinary shares of 10 pence each

ID Code: GB00B0LCW083

b)

Nature of the transaction

 

Release of a pledge by Darhold Limited over 1,000,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC in favour of Bank J. Safra Sarasin.  The Executive Vice Chairman is a director of and shareholder in Darhold Limited with an equity interest of 11.08%.

c)

Price(s) and volume(s)

Price(s): £0.00p

Volume(s): 1,000,000

d)

Aggregated information

Aggregated volume: 1,000,000

Price: £0.00p

e)

Date of the transaction

28 February 2020

f)

Place of the transaction

Amman

Mohammed 'Ali' Al-Husry

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Mohammed 'Ali' Al-Husry

2

Reason for the notification

a)

Position/status

Non-Executive Director

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Hikma Pharmaceuticals PLC

b)

LEI

549300BNS685UXH4JI75

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Description: Ordinary shares of 10 pence each

ID Code: GB00B0LCW083

b)

Nature of the transaction

 

Release of a pledge by Darhold Limited over 1,000,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC in favour of Bank J. Safra Sarasin.  The Non-Executive Director is a director of and shareholder in Darhold Limited with an equity interest of 8.13%.

c)

Price(s) and volume(s)

Price(s): £0.00p

Volume(s): 1,000,000

d)

Aggregated information

Aggregated volume: 1,000,000

Price: £0.00p

e)

Date of the transaction

28 February 2020

f)

Place of the transaction

Amman

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHBDGDDXDDDGGI

Quick facts: Hikma Pharmaceuticals PLC

Price: 2470

Market: AIM
Market Cap: £5.69 billion
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE